Phase I study of RG7155, a novel anti-CSF1R antibody, in patients with advanced/metastatic solid tumors. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback